Search

Search Constraints

You searched for: Author/Creator Lanman, Richard B.

Search Results

1. Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non–Small-Cell Lung Cancer. (2021)

2. Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA. Issue 10 (8th March 2018)

3. Circulating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancer. Issue 9 (8th January 2019)

4. Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. Issue 1 (17th September 2020)

5. Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. Issue 1 (17th September 2020)

6. Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance. (August 2019)

8. Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. (1st March 2018)

10. Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases. Issue 14 (4th May 2020)